Interleukin 10 reduces mortality from severe peritonitis in mice.
AUTOR(ES)
Kato, T
RESUMO
Interleukin 10 (IL-10) is known to suppress the induction of proinflammatory cytokines such as tumor necrosis factor (TNF) and IL-1 and is itself induced by monocytes and macrophages during sepsis. We studied the therapeutic efficacy of IL-10 by testing its effect on the survival rate in the murine cecal ligation-and-puncture (CLP) model. Administration of 1 microgram or more of recombinant murine IL-10 6 h after induction of sepsis decreased lethality in septic mice significantly and also suppressed the elevation of circulating TNF after sepsis. However, treatment with the same dose of IL-10 simultaneously or 6 h before induction of CLP had no effect on survival, and treatment with anti-TNF antibody after induction of CLP had no effect on the survival rate. These data suggest that cytokine modulation with IL-10 is a potential candidate for the treatment of sepsis and sepsis-related multiple organ failure.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162737Documentos Relacionados
- Effects of virally expressed interleukin-10 on vaccinia virus infection in mice.
- Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
- Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.
- Alveolar Macrophage Deactivation in Murine Septic Peritonitis: Role of Interleukin 10
- Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice.
